DNMT3A and posterior cortical atrophy: Plk1 is overexpressed in many cancers, including PCa,[10] and its depletion leads to PCa cell death.[26] DNMT3a, whose expression level is elevated in PCa, is a valid target as well.[27] However, whether and how Plk1 interacts with DNMT3a to contribute to PCa progression is unknown.